HESTER BIOSCIENCES LTD. SHARE PRICE [LIVE]

BSE: INE782E01017   NSE: HESTERBIO   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
2,276.75
Change:
BSE
2,286.60
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in HESTER BIOSCIENCES LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

HESTERBIO News

Frequently Asked Questions

What is the Share price of HESTER BIOSCIENCES LTD. (HESTERBIO)?

HESTER BIOSCIENCES LTD. (HESTERBIO) share price as of May 20, 2022, on NSE is Rs 2,276.75 (NSE) and Rs 2,286.60 (BSE) on BSE.

Can I buy HESTER BIOSCIENCES LTD. (HESTERBIO) shares?

Yes, You can buy HESTER BIOSCIENCES LTD. (HESTERBIO) shares by opening a Demat account with Angel One.

How do I buy HESTER BIOSCIENCES LTD. (HESTERBIO) from Angel One?

HESTER BIOSCIENCES LTD. (HESTERBIO) share can be brought through the following modes:
  1. Direct investment: You can buy HESTER BIOSCIENCES LTD. (HESTERBIO) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to HESTER BIOSCIENCES LTD. (HESTERBIO) shares.

In which sector do HESTER BIOSCIENCES LTD. (HESTERBIO) belong?

HESTER BIOSCIENCES LTD. (HESTERBIO) belongs to Pharma.

About HESTERBIO

Today's live share price for HESTER BIOSCIENCES LTD. is NSE: ₹ 2,276.75, BSE: ₹ 2,286.60 with a current market capitalization of .

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.

Read more